<DOC>
	<DOCNO>NCT01322867</DOCNO>
	<brief_summary>A Phase IV , Open Label , Randomized , Two-way Crossover , Single Dose Study Determine Relative Bioavailability Alprazolam 0,75mg/ml ( laboratórios Pfizer Ltda ) Oral Solution-drops Form , Versus Frontal® 0,25mg ( laboratórios Pfizer Ltda ) , Tablets Form , Under Fasted Conditions Healthy Volunteers .</brief_summary>
	<brief_title>A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) The BMI Body Mass Index volunteer within range 18,5 24,9 ( Dietary Guidelines Americans ) may vary 15 % due upper limit ( 18,5 28,63 ) total body weight &gt; 50kg An informed consent document sign date subject legally acceptable representative . If subject and/or legally acceptable representative read , informed consent document may sign impartial witness Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure Any condition possibly affect drug absorption ( eg , gastrectomy ) A history suicidal thought , behavior suicide attempt Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) Known hypersensitivity alprazolam component product History sensitivity heparin heparininduced thrombocytopenia A positive bHCG exam woman Subjects myasthenia gravis acute narrow angle glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>bioequivalence study</keyword>
	<keyword>alprazolam</keyword>
	<keyword>frontal</keyword>
</DOC>